ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,869,000 | -12.4% | 38,555 | -22.7% | 0.41% | -11.9% |
| Q4 2019 | $2,134,000 | +24.6% | 49,891 | +4.9% | 0.47% | +3.5% |
| Q3 2019 | $1,712,000 | -20.7% | 47,562 | -28.5% | 0.45% | +39.4% |
| Q2 2016 | $2,160,000 | +89.5% | 66,537 | +41.9% | 0.32% | +58.5% |
| Q1 2014 | $1,140,000 | -7.5% | 46,875 | -5.0% | 0.20% | -7.2% |
| Q4 2013 | $1,233,000 | -43.4% | 49,335 | -37.8% | 0.22% | -49.2% |
| Q3 2013 | $2,179,000 | -21.1% | 79,340 | -47.8% | 0.44% | -27.4% |
| Q2 2013 | $2,760,000 | – | 152,055 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |